Entries by دکتر امین اظهری

how exercise protects against consequences of ageing

Monash University scientists have discovered an enzyme that is key to why exercise improves our health. Importantly this discovery has opened up the possibility of drugs to promote this enzyme’s activity, protecting against the consequences of ageing on metabolic health, including type 2 diabetes. The proportion of people worldwide over 60 years old will double […]

, ,

Immune memory less durable after severe COVID-19

Infection-fighting B cells retain better memory of the coronavirus spike protein in University Hospital patients who recover from less-severe cases of COVID-19 than in those recovering from severe COVID-19, a new study suggests. Findings by scientists from The University of Texas Health Science Center at San Antonio were published in the journal PLOS ONE . […]

, , , , , , , ,

Metabolic syndrome increases risk of respiratory distress, death for hospitalized COVID-19 patients

Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity, diabetes or other conditions associated with metabolic syndrome were at much higher risk of acute respiratory distress syndrome (ARDS) and death, according to an international study published in the medical journal JAMA Network Open. The risk for developing ARDS, a life-threatening lung […]

Infant Immune Systems Are Stronger Than You Think

New study may help explain why infants are less affected by COVID than adults.  The infant immune system has a reputation for being weak and underdeveloped when compared to the adult immune system, but the comparison isn’t quite fair. Babies do get a lot of respiratory illnesses from viruses, like influenza and respiratory syncytial virus, […]

Triggers of stroke: anger, emotional upset, and heavy physical exertion

global study co-led by NUI Galway into causes of stroke has found that one in 11 survivors experienced a period of anger or upset in the one hour leading up to it. One in 20 patients had engaged in heavy physical exertion. The suspected triggers have been identified as part of the global INTERSTROKE study […]

,

ALS therapy should target brain, not just spine

The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered. This flips a long-standing belief that the disease starts in the spinal motor neurons and any therapy would need to target the spine as the key focus. A new Northwestern study shows the degeneration of brain motor neurons […]

HOW REGULAR EXERCISE CAN PROTECT AGAINST FATTY LIVER ASSOCIATED DISEASES

Worldwide one in four persons suffers from non-alcoholic liver disease (NAFLD, also called metabolic liver disease MAFLD). Those affected often have type 2 diabetes as well as an increased risk of liver cirrhosis and cardiovascular diseases. In addition, NAFLD is associated with increased mortality. An imbalance between energy intake and consumption is discussed as a […]

Ultrasound could be used to treat psychiatric disorders

Imagine passing an exam, and thinking your success was down to the socks you wore or the number of biscuits you’d eaten, rather than the hours of study you’d put in. This is an issue of ‘credit assignment’, where a person or animal attributes the wrong outcome to an event, exists in a variety of […]

Greater Exposure to Nitrogen Dioxide Linked to Higher Levels of Biomarkers of Alzheimer Disease in the Brain

A study has found an association between air pollution and higher levels of deposition of beta-amyloid protein in the brain and of neurofilament light (NfL) in cerebrospinal fluid. Investigators from the Barcelonaβeta Brain Research Center (BBRC), the research arm of the Pasqual Maragall Foundation, in collaboration with ISGlobal, have found an association between exposure to […]

Drug could more effectively treat patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial led by the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia. An antibody already in late-stage trials to treat rheumatoid arthritis, namilumab targets a ‘cytokine’ which is naturally secreted by immune cells in the body but, in […]